Treatment of genetic screening of hypertriglyceridemia type I, III, and V

This is a cohort of patients with extreme hypertriglyceridemia. Patients have been screened for loss of function mutations in LPL, GPIHBP1, APOC2, APOA5 and LMF1.

本数据集为极重度高甘油三酯血症（extreme hypertriglyceridemia）患者队列。已对入组患者开展针对LPL、GPIHBP1、APOC2、APOA5及LMF1基因功能丧失突变的筛查。